A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes

This study was not conducted in the United States. The purpose of this study was to assess the safety and effectiveness of a number of doses of vildagliptin, an unapproved drug, in the treatment of people with type 2 diabetes.

本研究未在美国开展。本研究旨在评估未获批药物维格列汀（vildagliptin）的多种给药剂量用于治疗2型糖尿病患者的安全性与有效性。